Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Goodwill: 2009-2025

Historic Goodwill for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $980.9 million.

  • BIO-TECHNE's Goodwill fell 0.37% to $978.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $978.9 million, marking a year-over-year decrease of 0.37%. This contributed to the annual value of $980.9 million for FY2025, which is 0.85% up from last year.
  • Per BIO-TECHNE's latest filing, its Goodwill stood at $980.9 million for FY2025, which was up 0.85% from $972.7 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Goodwill registered a high of $980.9 million during FY2025, and its lowest value of $822.1 million during FY2022.
  • Moreover, its 3-year median value for Goodwill was $972.7 million (2024), whereas its average is $942.1 million.
  • Its Goodwill has fluctuated over the past 5 years, first grew by 15.76% in 2021, then fell by 2.49% in 2022.
  • BIO-TECHNE's Goodwill (Yearly) stood at $843.1 million in 2021, then declined by 2.49% to $822.1 million in 2022, then climbed by 6.16% to $872.7 million in 2023, then increased by 11.45% to $972.7 million in 2024, then grew by 0.85% to $980.9 million in 2025.